Replies to post #131540 on Biotech Values

[biomaven0]

>INCY

I recently re-entered with a modest position, but the decline has continued since then. I'll likely add at some point.

The label was as good or better than expected, so I don't really see what the market is complaining about. If its competition from YMI that's the concern, then maybe the play is to buy a bit of it too as a hedge.

Peter